[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![Sarepta Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::2216555822.png) Sarepta Therapeutics [@Sarepta](/creator/twitter/Sarepta) on x 6191 followers
Created: 2025-04-15 12:34:34 UTC

Today we shared updates from our clinical programs focused on limb-girdle muscular dystrophy (LGMD) subtypes 2C/R5, 2D/R3 and 2E/R4. Read more here:

![](https://pbs.twimg.com/media/Gok5HY2WgAAI766.jpg)

XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1912122376738779536/c:line.svg)

**Related Topics**
[sarepta therapeutics](/topic/sarepta-therapeutics)

[Post Link](https://x.com/Sarepta/status/1912122376738779536)